ReviewBritish journal of haematology2020
Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.
Review in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.Frontiers in medicine · 2023Pooled it
- Article
- COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.Journal of medical virology · 2021Article
- A review on how to do hematology consults during COVID-19 pandemic.Blood reviews · 2021Review
- Simultaneous diagnosis of severe SARS-CoV-2 infection and sickle cell disease in two infants.Blood transfusion = Trasfusione del sangue · 2021Article
- COVID-19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange.Clinical case reports · 2021Article
- Presentation, management, and outcomes of COVID-19 in patients with sickle cell disease.EJHaem · 2021Article
- Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.Laboratory medicine · 2021Review
- Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease.Frontiers in medicine · 2021Article
- Management of Sickle Cell Disease Complications Beyond Acute Chest Syndrome.Journal of blood medicine · 2021Review
- COVID-19 and sickle cell disease in Bahrain.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020Article
- Current Perspectives of convalescent plasma therapy in COVID-19.Acta bio-medica : Atenei Parmensis · 2020Review
- Challenges for management of immune thrombocytopenia during COVID-19 pandemic.Journal of medical virology · 2020Article
- Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.British journal of haematology · 2020Review
- Trajectory of the COVID-19 pandemic: chasing a moving target.Annals of translational medicine · 2020Review
- COVID-19 Pandemic and Children: A Review.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2020Review
- Hemoglobinopathy and pediatrics in the time of COVID-19.Hematology, transfusion and cell therapyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.